Status | Study |
Terminated |
Study Name: L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients Condition: Bronchiolitis Obliterans Date: 2011-04-11 Interventions: Drug: Cyclosporine Inhalation Solution Cyclosporin for inhalation twice daily |
Terminated |
Study Name: Efficacy Study of Azithromycin-based Therapy for Bronchiolitis Obliterans Condition: Graft vs Host Disease Bronchiolitis Obliterans Date: 2011-03-31 Interventions: Drug: azithromycin + N-acetylcystein + inhaled corticosteroid |
Completed |
Study Name: Clinical Status and Bronchial Inflammation in Patients With Bronchiolitis Obliterans Condition: Bronchiolitis Obliterans Date: 2011-03-30 |
Completed |
Study Name: Targeted Therapy of Bronchiolitis Obliterans Syndrome Condition: Bronchiolitis Obliterans Date: 2011-03-01 Interventions: Drug: fluticasone propionate G |
Recruiting |
Study Name: Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for the Treatment of Bronchiolitis Obliterans Condition: Bronchiolitis Obliterans Graft vs Host Disease Date: 2011-01-29 Interventions: Drug: Cyclosporine Inhalation Solution |
Completed |
Study Name: Montelukast in Bronchiolitis Obliterans Syndrome Condition: Bronchiolitis Obliterans Lung Transplantation Date: 2010-09-28 Interventions: Drug: Montelukast After diagnosis of fBOS every day an oral capsule with 10 mg montelukast of placebo |
Completed |
Study Name: Vitamin D in Bronchiolitis Obliterans Syndrome Condition: Allograft Rejection Lung Transplantation Date: 2010-09-28 Interventions: Drug: Vitamin D Every month 100.000 units of vitamin D in syringe Exacta-Med Oral Dispenser during 2 yea |
Active, not recruiting |
Study Name: A Proposal to Test the Efficacy and Tolerability of Bortezomib in Pulmonary Chronic GVHD Condition: Bronchiolitis Obliterans Date: 2010-07-07 Interventions: Drug: Bortezomib Each patient will receive 2 cycles of Bortezomib. For each cycle Bortezomib wil be give |
Completed |
Study Name: A Study to Evaluate the Potential of Mesenchymal Stromal Cells to Treat Obliterative Bronchiolitis After Lung Transplantation Condition: Bronchiolitis Obliterans Lung Transplantation Date: 2010-06-25 Interventions: Other: MSC mesenchymal stromal cells (MSC), aiming for 2 x 106 /kg cells recipient body weight, aiming f |
Completed |
Study Name: Bronchodilator Responsiveness in Obliterative Bronchiolitis Condition: Obliterative Bronchiolitis Date: 2010-04-27 Interventions: Drug: albuterol plus tiotropium Four separate doses of 100 μg of albuterol and 18 μg of tiotro |